Norepinephrine-associated left ventricular outflow tract obstruction and systolic anterior movement

BMJ Case Rep. 2019 Dec 2;12(12):e225879. doi: 10.1136/bcr-2018-225879.

Abstract

In the perioperative setting, norepinephrine is used to increase blood pressure, an effect mediated mostly via arterial and venous vasoconstriction. Thus, norepinephrine is, allegedly, less likely to cause or worsen left ventricular outflow tract obstruction (LVOTO) than other inotropes. We report a case of norepinephrine-associated dynamic LVOTO and systolic anterior movement in a predisposed patient. This report highlights that unrecognised dynamic LVOTO may worsen shock parameters in patients treated with norepinephrine who have underlying myocardial hypertrophy.

Keywords: adult intensive care; cardiovascular system; contraindications and precautions; drug therapy related to surgery; unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Cardiomyopathy, Hypertrophic / complications
  • Cardiomyopathy, Hypertrophic / therapy
  • Echocardiography, Doppler, Color
  • Fatal Outcome
  • Humans
  • Male
  • Mitral Valve / physiopathology
  • Norepinephrine / administration & dosage
  • Norepinephrine / adverse effects*
  • Norepinephrine / pharmacology
  • Vasoconstrictor Agents / administration & dosage
  • Vasoconstrictor Agents / adverse effects*
  • Vasoconstrictor Agents / pharmacology
  • Ventricular Outflow Obstruction / chemically induced*

Substances

  • Vasoconstrictor Agents
  • Norepinephrine